19 related articles for article (PubMed ID: 15837538)
1. Clinical significance of immune-related antigen CD58 in gliomas and analysis of its potential core related gene clusters.
Tian Z; Jia W; Wang Z; Mao H; Zhang J; Shi Q; Li X; Song S; Zhang J; Zhu Y; Yang B; Huang C; Huang J
Heliyon; 2024 Apr; 10(8):e29275. PubMed ID: 38699747
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity.
Mukherjee J; Sarkar S; Ghosh A; Duttagupta AK; Chaudhuri S; Chaudhuri S
Toxicol Lett; 2004 May; 150(3):239-57. PubMed ID: 15110076
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status.
Mukherjee J; Ghosh A; Sarkar P; Mazumdar M; Banerjee C; Chaudhuri S
Anticancer Res; 2005; 25(4):2905-19. PubMed ID: 16080544
[TBL] [Abstract][Full Text] [Related]
4. ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells.
Mukherjee J; Ghosh A; Ghosh A; Chaudhuri S
Cancer Biol Ther; 2006 Feb; 5(2):156-64. PubMed ID: 16357521
[TBL] [Abstract][Full Text] [Related]
5. Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy.
Sarkar S; Begum Z; Dutta S; Dutta SK; Chaudhuri S; Chaudhuri S
J Exp Clin Cancer Res; 2002 Mar; 21(1):95-106. PubMed ID: 12071536
[TBL] [Abstract][Full Text] [Related]
6. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.
Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S
Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439
[TBL] [Abstract][Full Text] [Related]
7. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR.
Mukherjee J; Ghosh A; Sarkar S; Mazumdar M; Sarkar P; Duttagupta AK; Chaudhuri S
Cancer Lett; 2005 May; 222(1):23-38. PubMed ID: 15837538
[TBL] [Abstract][Full Text] [Related]
8. [Arbitrarily primed PCR: an unique technique for molecular genetical analysis].
Yasuda J
Tanpakushitsu Kakusan Koso; 1996 Apr; 41(5):568-72. PubMed ID: 8650344
[No Abstract] [Full Text] [Related]
9. Therapeutic intervention of glioma with the novel antineoplastic agent T11TS: the story so far.
Chaudhuri S; Acharya S; Chaudhuri S
Immunotherapy; 2022 Oct; 14(15):1263-1277. PubMed ID: 36004447
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]